GSK Leads Way With Real World Data, But Others Follow – The Pink Sheet
Dan Renick comments on the importance of value demonstration for respiratory disease treatments in The Pink Sheet.
(more…)
What’s the Deal – The Wall Street Journal
Pharma Industry Firm Moves for More Space
Precision for Value, a company that helps bring pharmaceutical products to market, has found a larger home at One Grand Central Place.
Press Release: Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor
Los Angeles, May 17, 2016 — Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.
How to Apply Objection-Handling to Drug Price Complaint – PM360
Dan Renick comments on the burden of out-of-pocket patient costs for specialty medications in PM360.
You Can’t Just Ban Twinkies (Darius Lakdawalla interview) – BBC Radio
Precision’s Lakdawalla on the BBC: ‘You can’t just ban Twinkies’
Precision’s Darius Lakdawalla was recently interviewed for the BBC’s Business Daily program, discussing the trend to ban large size sodas and other recent anti-junk food measures.
AMCP Corporate Member Spotlight: Precision for Value President Dan Renick -AMCP News & Views
AMCP News&Views caught up recently with Dan Renick, BS Pharmacy, RPh, President of Precision for Value, to get his thoughts on becoming a corporate member and innovations at his company.
Biosimilars: What’s in a Name? – Pharmaceutical Commerce Magazine
Precision for Value’s Jeremy Schafer is quoted in an article that discusses the naming of biosimilars. He concludes that the payer community will find a way to track biosimilar sourcing, usage and reimbursement regardless of naming conventions or HCPCS codes.
Precision for Medicine acquires Redwood Outcomes, a Canadian HEOR firm – Pharmaceutical Commerce Magazine
Precision for Value, a unit of New York-based Precision for Medicine, is adding Redwood Outcomes, based in Vancouver, BC to its stable.
Precision for Value Acquires Redwood Outcomes – NJBIZ
Dan Renick is quoted in NJBIZ on Precision’s Redwood Outcomes HEOR acquisition.
Precision for Value Buys Health Economics Firm – Medical Marketing & Media
Precision’s acquisition of Redwood Outcomes is noted in Medical Marketing & Media.